» Articles » PMID: 29123668

NanoEHS Beyond Toxicity - Focusing on Biocorona

Overview
Date 2017 Nov 11
PMID 29123668
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The first phase of environmental health and safety of nanomaterials (nanoEHS) studies has been mainly focused on evidence-based investigations that probe the impact of nanoparticles, nanomaterials and nano-enabled products on biological and ecological systems. The integration of multiple disciplines, including colloidal science, nanomaterial science, chemistry, toxicology/immunology and environmental science, is necessary to understand the implications of nanotechnology for both human health and the environment. While strides have been made in connecting the physicochemical properties of nanomaterials with their hazard potential in tiered models, fundamental understanding of nano-biomolecular interactions and their implications for nanoEHS is largely absent from the literature. Research on nano-biomolecular interactions within the context of natural systems not only provides important clues for deciphering nanotoxicity and nanoparticle-induced pathology, but also presents vast new opportunities for screening beneficial material properties and designing greener products from bottom up. This review highlights new opportunities concerning nano-biomolecular interactions beyond the scope of toxicity.

Citing Articles

Environmental Health and Safety Implications of the Interplay Between Microplastics and the Residing Biofilm.

Wu X, He F, Xu X, Wu L, Rong J, Lin S Environ Health (Wash). 2025; 3(2):118-132.

PMID: 40012871 PMC: 11851218. DOI: 10.1021/envhealth.4c00148.


Protein Corona Formation on Cadmium-Bearing Nanoparticles: Important Role of Facet-Dependent Binding of Cysteine-Rich Proteins.

Qi Y, Guan W, Jiang C, Chen W, Zhang T Environ Health (Wash). 2024; 2(9):623-630.

PMID: 39512393 PMC: 11540113. DOI: 10.1021/envhealth.4c00031.


Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines.

Havelikar U, Ghorpade K, Kumar A, Patel A, Singh M, Banjare N Discov Nano. 2024; 19(1):165.

PMID: 39365367 PMC: 11452581. DOI: 10.1186/s11671-024-04118-1.


Remediation of Metal Oxide Nanotoxicity with a Functional Amyloid.

Wang Y, Liang X, Andrikopoulos N, Tang H, He F, Yin X Adv Sci (Weinh). 2024; 11(23):e2310314.

PMID: 38582521 PMC: 11187920. DOI: 10.1002/advs.202310314.


SciRAPnano: a pragmatic and harmonized approach for quality evaluation of toxicity data to support risk assessment of nanomaterials.

Shao G, Beronius A, Nymark P Front Toxicol. 2023; 5:1319985.

PMID: 38046400 PMC: 10691260. DOI: 10.3389/ftox.2023.1319985.


References
1.
Dimkpa C, McLean J, Britt D, Johnson W, Arey B, Lea A . Nanospecific inhibition of pyoverdine siderophore production in Pseudomonas chlororaphis O6 by CuO nanoparticles. Chem Res Toxicol. 2012; 25(5):1066-74. DOI: 10.1021/tx3000285. View

2.
Liu S, Zeng T, Hofmann M, Burcombe E, Wei J, Jiang R . Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano. 2011; 5(9):6971-80. DOI: 10.1021/nn202451x. View

3.
Ding F, Furukawa Y, Nukina N, Dokholyan N . Local unfolding of Cu, Zn superoxide dismutase monomer determines the morphology of fibrillar aggregates. J Mol Biol. 2012; 421(4-5):548-60. PMC: 3320695. DOI: 10.1016/j.jmb.2011.12.029. View

4.
Xia T, Malasarn D, Lin S, Ji Z, Zhang H, Miller R . Implementation of a multidisciplinary approach to solve complex nano EHS problems by the UC Center for the Environmental Implications of Nanotechnology. Small. 2012; 9(9-10):1428-43. DOI: 10.1002/smll.201201700. View

5.
Lin C, Lu T . C60 fullerene derivatized nanoparticles and their application to therapeutics. Recent Pat Nanotechnol. 2012; 6(2):105-13. DOI: 10.2174/187221012800270135. View